0001062993-18-001261.txt : 20180319 0001062993-18-001261.hdr.sgml : 20180319 20180319182611 ACCESSION NUMBER: 0001062993-18-001261 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180315 FILED AS OF DATE: 20180319 DATE AS OF CHANGE: 20180319 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mattila Jyrki CENTRAL INDEX KEY: 0001297318 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34236 FILM NUMBER: 18700142 MAIL ADDRESS: STREET 1: AUXILIUM PHARMACEUTICALS, INC. STREET 2: 40 VALLEY STREAM PARKWAY CITY: MALVERN STATE: PA ZIP: 19355 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP CENTRAL INDEX KEY: 0000875622 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113054851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 WILBUR ST CITY: LYNBROOK STATE: NY ZIP: 11563 BUSINESS PHONE: 5165937000 MAIL ADDRESS: STREET 1: 35 WILBUR STREET CITY: LYNBROOK STATE: NY ZIP: 11563 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2018-03-15 0000875622 BIOSPECIFICS TECHNOLOGIES CORP BSTC 0001297318 Mattila Jyrki C/O BIOSPECIFICS TECHNOLOGIES CORP. 35 WILBUR STREET LYNBROOK NY 11563 1 0 0 0 Stock Option (Right to Buy) 41.82 2018-03-15 4 A 0 15000 0 A 2028-03-15 Common Stock 15000 15000 D The options were granted on March 15, 2018, and will vest in four equal annual installments beginning on the first anniversary of the grant date. /s/ Jyrki Mattila, by Carl A. Valenstein, attorney-in-fact 2018-03-19